National Institute for Health and Clinical Excellence (NICE)
NICE launches online resource to help development and adoption of new health technologies
HealthTech Connect, a new online resource provided by NICE to help identify and support new health technologies as they move from inception to adoption in the UK health and care system was formally launched today (29 April).
Developed by NICE with help from a range of partner organisationsi and funding from NHS England, HealthTech Connect is for health technologies (medical devices and diagnostic and digital health technologies) that:
- offer measurable benefits to patients (or other health and care service users) compared to those already offered by current routine practice in the UK, or
- provide measurable benefits to the UK health and care system compared to those already offered by current routine practice in the UK.
The system, which is free to use, will help companies to understand what information is needed by decision makers in the UK health and care system, and clarify possible routes to market access. It will also help the UK health and care system to better plan for the introduction and adoption of health technologies - for example by reconfiguring services or enabling reimbursement.
Once registered, companies enter and update information about their technology as it develops into www.HealthTechConnect.org.uk. This information is used to determine if the technology is suitable for consideration by an organisation that offers support to health technology developers; for example with funding, technology development, evidence generation, market access, reimbursement, adoption.
It will also be used to identify if the technology is suitable for consideration for evaluation by a UK health technology assessment programme.
Technologies that are suitable for support or evaluation will be able to access this through HealthTech Connect. This will avoid companies having to provide the same or similar information about their technology separately to a different organisation or programme.
Meindert Boysen, director of the Centre for Health technology Evaluation at NICE, said: “HealthTech Connect is a clear and simple point of entry for companies developing health technologies, be it medical devices, diagnostics or digital health technologies, to access support and potential routes to national evaluation programmes.
“As well as helping national organisations like NICE, that have a responsibility for developing guidance on the use of health technologies in the NHS, better identify and track technologies that offer novel benefits, HealthTech Connect will also enable transformative technologies to be identified and fast tracked through relevant processes within the Accelerated Access Collaborative.
“Ultimately the aim of HealthTech Connect is to help get promising new health technologies to the people who will benefit from them, faster. We expect it to contribute to reducing the complexity, and often duplication, involved in getting medical devices, diagnostics and digital health technologies adopted in the UK.”
Since the initial “soft” launch of the system in February, over 100 companies have registered to use HealthTech Connect, 13 technologies have been submitted, and 1 technology [Sonata System] has already been selected by NICE for a Medtech Innovation Briefing
Sarah Field, sales manager UK & Ireland for Gynesonics, said: “The HealthTech Connect portal was a great way to interface the interaction between our organisation and NICE. This enabled a swift pathway for our new technology (the Sonata treatmentii) to be evaluated. I thoroughly recommend other commercial organisations to use this route. The registration process was quick and simple. This is a really helpful initiative.”
Further information about HealthTech Connect is available at the HealthTech Connect website
- ABHI, AXREM, BIVDA), NIHR and the NIHR Innovation Observatory, the AHSN network, Office for Life Sciences, MHRA, NHS Clinical Commissioners, NHS Supply chain and the devolved administrations in Wales, Scotland, and Northern Ireland.
- The Sonata System combines real-time intrauterine ultrasound guidance with targeted radiofrequency ablation in an incisionless procedure to treat symptomatic uterine fibroids.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE 20th Anniversary: Parliamentary Reception and Awards14/06/2019 14:15:00
NICE has hosted a parliamentary reception and awards ceremony in celebration of its 20th anniversary.
Employers encouraged to help their staff become active in fight against obesity06/06/2019 13:25:00
A fit and energised workforce is less likely to be off sick and more satisfied in their jobs
NICE commissions expert advice on EQ-5D-5L22/05/2019 12:15:00
Blog posted by: Rosie Lovett, Science policy and research programme, 21 May 2019.
Shared Learning Awards 2019: Winning example announced21/05/2019 16:15:00
Pancreatic Cancer UK and University Hospital Birmingham pick up first prize.
NICE recommends first ever treatment for children with rare muscle-wasting condition16/05/2019 11:15:00
Children with the rare genetic disorder spinal muscular atrophy (SMA) can now be treated with nusinersen after NICE yesterday (15 May) recommended it following agreement of a deal between the company, Biogen, and NHS England.
Lower price for MS drug paves the way for positive recommendation from NICE10/05/2019 12:15:00
A new, lower price for a drug to treat a rarer form of multiple sclerosis in adults has paved the way for its approval by NICE.
The Scarred Liver Project: A new diagnostic pathway to detect chronic liver disease09/05/2019 10:42:00
Blog posted by: Neil Guha, clinical associate professor in hepatology, Nottingham University Hospitals NHS Trust, 08 May 2019.
The perinatal mental health (PMH) matrix: Improving the quality of care for women with PMH issues08/05/2019 16:48:00
Blog posted by: Sarah Fishburn, quality improvement lead, Thames Valley Strategic Clinical Network, 08 May 2019.